Llwytho...
A Pilot Study of Website Information Regarding Aromatase Inhibitors: Dietary Supplement Interactions
OBJECTIVES: Patients who have hormone receptor–positive breast cancer and who are taking aromatase inhibitors (AIs) should understand the benefits and risks of concomitant dietary supplement (DS) use. The International Society for Integrative Oncology (SIO) encourages patients to discuss DS use with...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Mary Ann Liebert, Inc.
2011
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3221507/ https://ncbi.nlm.nih.gov/pubmed/22087614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/acm.2010.0471 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|